TTrialPathMatch Me to Trials
← Back to trials
RecruitingSleep Apnea, Obstructive

Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea

Eligible age

30–75 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.

Sponsor: Ohio State University

You may qualify if…

  • 30 to 75 years of age
  • Among patients with hypertension, no change in BP medication for at least 3 months.
  • Willing and able to give informed consent
  • Willing and able to complete ambulatory blood pressure monitoring at baseline and after 6-months.
  • Sleep study \[Polysomnography (PSG) or Home Sleep Apnea Study (HSAT) performed based on clinical grounds
  • 4% oxygen desaturation index (ODI4) ≥15 events/hour on clinical sleep study
  • Planned CPAP treatment by treating provider

You may not qualify if…

  • Unable to apply BP cuff (e.g. arm circumference \>55 cm, prior breast cancer, structural abnormalities of the arm)
  • Current use of CPAP or Dental Device for OSA
  • Category III-IV of heart failure
  • Presence of Cheyne-Stokes Respiration (CSR) in PSG
  • Predominantly central sleep apnea (AHI≥15 events/hour)
  • Pregnancy
  • History of renal failure, or renal transplant
  • Self-reported sleep duration less than 5 hours per night on weeknights (work nights)

Where it's recruiting

Ohio

Columbus

Source: ClinicalTrials.gov · NCT04712656 · last updated 2025-07-24